APPLICATION
NDA008951
TYPE
NDA
ORIGINAL APPROVAL
1953-07-22
LATEST ACTION
1953-07-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
PAGITANEDiscontinued
CYCRIMINE HYDROCHLORIDE 2.5MG · TABLET · ORAL
PAGITANEDiscontinued
CYCRIMINE HYDROCHLORIDE 1.25MG · TABLET · ORAL
Approval history
1953-07-22Type 1 - New Molecular Entity · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.